ArticleJournal of cancer research and clinical oncology2023

Immunotherapy with cure potential of multi-drug resistant hematologic malignancies using IL-2 preactivated intentionally mismatched donor lymphocyte.

Shimon SlavinPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.